NCT02806388Recruiting
Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
Source: ClinicalTrials.gov · Last updated 13 May 2026
Brief summary (registry, in English)
This study aims to screen tumor molecular profile for better selection of anticancer treatment, in particular, allocation to clinical trials if available.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 5500 (estimated)
- First submitted
- 16 Jun 2016
- Start date
- 1 Oct 2011
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- National Cancer Centre, Singapore
- Diseases
- Childhood cancers
- NCT number
- NCT02806388
What you commit to
- Study type: Observational
- Planned participants: 5500
- From 1 Oct 2011 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- Confirmed histological diagnosis of solid tumor
- Suitable for systematic treatment and clinical trials
- ECOG (Eastern cooperative oncology group) performance status \< 2
- Able to provide tumor tissue for molecular profiling
- Able to understand and sign the informed consent form
Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Cancer Centre Singapore Coordinator of this site? Confirm its status | Singapore | Singapore | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.